Financials
- Market Capitalization 1.01 B
- Employee 260
- Founded 2014
- CEO N/A
- Website www.kuraoncology.com
- Headquarter Delaware, United States
- FIGI BBG008974342
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2427 | ANNX Annexon, Inc. - common stock | 6.50 USD | +17.12% | +10.54% | +43.17% | +173.11% | 1.06 B USD | ||
| 2448 | OLMA Olema Pharmaceuticals, Inc. - Common Stock | 11.82 USD | -0.25% | -3.04% | +28.62% | +44.32% | 1.03 B USD | ||
| 2480 | SANA Sana Biotechnology, Inc. - Common Stock | 3.55 USD | -0.56% | -10.80% | +24.56% | -17.63% | 987.94 M USD | ||
| 2484 | VOR Vor Biopharma Inc. - Common Stock | 18.08 USD | -2.27% | -10.85% | +26.17% | +38.02% | 979.68 M USD |
Frequently asked questions about Kura Oncology, Inc. - Common Stock
What is the Kura Oncology, Inc. - Common Stock stock price today?
The current price of Kura Oncology, Inc. - Common Stock (KURA) is 11.33. Over the past 24 hours, the stock has changed by +0.80%. Follow the KURA chart for real-time price dynamics.
What is the stock ticker of Kura Oncology, Inc. - Common Stock?
Kura Oncology, Inc. - Common Stock trades under the ticker KURA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Kura Oncology, Inc. - Common Stock stock going up?
KURA has changed by -6.29% over the last week, +19.14% over the last month, and +77.31% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Kura Oncology, Inc. - Common Stock net income for the last quarter?
Kura Oncology, Inc. - Common Stock reported net income of -73.33 M for the last quarter. The previous quarter showed -81 M, which means net income changed by +9.46%.
How many employees does Kura Oncology, Inc. - Common Stock have?
As of the latest available data, Kura Oncology, Inc. - Common Stock has 260 employees. Workforce size can provide additional context about the company's scale and operations.
What is Kura Oncology, Inc. - Common Stock EBITDA?
Kura Oncology, Inc. - Common Stock EBITDA is -79.25 M, and its EBITDA margin is -433.91%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Kura Oncology, Inc. - Common Stock stock?
You can buy Kura Oncology, Inc. - Common Stock (KURA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Kura Oncology, Inc. - Common Stock stock?
Investing in Kura Oncology, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the KURA chart and related analysis on metatrader.com as part of your research.